实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (3): 337-340.doi: 10.3969/j.issn.1672-5069.2026.03.005

• 病毒性肝炎 • 上一篇    下一篇

CT肝细胞外基质体积分数联合血清NOX2和YKL-40水平评估慢性乙型肝炎肝纤维化程度价值研究*

刘建晓, 王燕, 陈世成, 董月稳, 刘向芹, 薛云, 王天赐, 张凯   

  1. 054000 河北省邢台市中心医院检验科(刘建晓,陈世成,董月稳,刘向芹,薛云,王天赐,张凯);邢台医学院第二附属医院消化内科(王燕)
  • 收稿日期:2025-11-01 出版日期:2026-05-10 发布日期:2026-05-18
  • 作者简介:刘建晓,女,41岁,医学硕士,副主任检验技师。E-mail:liujianxiao2025@163.com
  • 基金资助:
    *河北省邢台市科技局重点研发计划项目(编号:2024ZC218)

CT-measured extracellular volume fraction in combination with serum NOX2 and YKL-40 levels in predicting hepatic fibrosis in patients with chronic hepatitis B

Liu Jianxiao, Wang Yan, Chen Shicheng, et al   

  1. Clinical Laboratory, Central Hospital, Xingtai 054000, Hebei Province, China
  • Received:2025-11-01 Online:2026-05-10 Published:2026-05-18

摘要: 目的 探讨CT肝细胞外基质体积分数(fECV)联合血清烟酰胺腺嘌呤二核苷酸磷酸氧化酶2(NOX2)和几丁质酶样蛋白40(YKL-40)诊断慢性乙型肝炎(CHB)患者肝纤维化(HF)程度的价值。方法 2023年5月~2025年5月邢台市中心医院收治的113例CHB患者,均接受CT检查测量fECV和肝穿刺活检,采用ELISA法检测血清NOX2和YKL-40水平。采用多因素Logistic回归分析影响CHB患者HF程度的因素,应用受试者工作特征曲线(ROC)及其曲线下面积(AUC)评估诊断效能。结果 在113例CHB患者中,经组织病理学检查诊断F0期13例,F1期34例(非显著性HF者47例),F2期38例,F3期18例(显著性HF者56例)和F4期10例;显著性HF组fECV、血清NOX2和YKL-40水平分别为(35.1±10.4)%、(16.8±3.4)ng/mL和(31.1±8.2)ng/mL,均显著高于非显著性HF组【分别为(26.9±7.6)%、(9.6±2.5)ng/mL和(21.6±6.5)ng/mL,P<0.05】;多因素Logistic回归分析显示,fECV(OR=1.696,95%CI:1.057~2.719)、NOX2(OR=1.853,95%CI:1.025~3.350)和YKL-40(OR=0.441,95%CI:1.044~2.314)均是影响CHB患者HF程度的独立影响因素;ROC曲线显示,fECV联合血清NOX2和YKL-40水平预测CHB患者显著性HF的AUC为0.914(95%CI:0.842~0.960),其敏感度为92.9%,特异度为76.6%,显著优于单一指标预测(P<0.05)。结论 fECV联合血清NOX2和YKL-40水平可初步辅助判断CHB患者HF程度,为进一步诊治提供参考依据。

关键词: 乙型肝炎, 肝纤维化, CT扫描, 肝细胞外基质体积分数, 烟酰胺腺嘌呤二核苷酸磷酸氧化酶2, 几丁质酶样蛋白40, 诊断

Abstract: Objective The aim of this study was to investigate CT-measured extracellular volume fraction (fECV) in combination with serum nicotinamide adenosine diphosphate oxidase 2 (NOX2) and chitinase-3-like protein 1 (YKL-40) levels in predicting hepatic fibrosis (HF) in patients with chronic hepatitis B (CHB). Methods A total of 113 patients with CHB were encountered in Xingtai Central Hospital between May 2023 and May 2025, and all of them underwent CT scan to measure fECV and liver biopsy. Serum NOX2 and YKL-40 levels were detected by ELISA. Multivariate Logistic regression analysis was applied to analyze the factors influencing the degree of HF in patients with CHB, and the receiver operating characteristic (ROC) curve and its area under the curve (AUC) were used to evaluate diagnostic efficacy. Results Of the 113 patients with CHB, liver histo-pathological examination found stage F0 of HF in 13 cases, stage F1 in 34 cases (e.g., non-significant HF in 47 cases),stage F2 in 38 cases, stage F3 in 18 cases (significant HF in 56 cases), and stage F4 in 10 cases; fECV, serum NOX2 and YKL-40 levels in significant HF group were (35.1±10.4)%, (16.8±3.4)ng/mL and (31.1±8.2)ng/mL, all much higher than [(26.9±7.6)%, (9.6±2.5)ng/mL and (21.6±6.5)ng/mL, respectively,P<0.05] in non-significant HF group; multivariate Logistic regression analysis showed that fECV(OR=1.696,95%CI:1.057-2.719), NOX2(OR=1.853,95%CI:1.025-3.350) and YKL-40(OR=0.441,95%CI:1.044-2.314) were all the independent impacting factors for HF in patients with CHB; ROC analysis demonstrated that the AUC was 0.914(95%CI:0.842-0.960),with sensitivity of 92.9% and specificity of 76.6%, when the fECV was combined with serum NOX2 and YKL-40 levels in predicting significant HF in patients with CHB, much superior to any single parameter doing (P<0.05). Conclusion The combination of fECV, and serum NOX2 and YKL-40 levels could help clinicians initially screen liver fibrosis in patients with CHB, which might lead to further management.

Key words: Hepatitis B, Hepatic fibrosis, CT scan, Extracellular volume fraction, Nicotinamide adenosine diphosphate oxidase 2, Chitinase-3-like protein 1, Diagnosis